Menin regulates spinal glutamate-GABA balance through GAD65 contributing to neuropathic pain

Pharmacological Reports

Volumn 66, Issue 1, 2014, Pages 49-55

  Shen, Xiaofeng ^a   Liu, Yusheng ^a   Xu, Shiqin ^a   Zhao, Qingsong ^a   Wu, Haibo ^a   Guo, Xirong ^a   Shen, Rong ^a   Wang, Fuzhou ^a,b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Division of Neuroscience Bonoi Academy of Science and Education   (United States)

Author keywords

Epigenetics; Menin; Neuropathic pain; Neurotransmitter; Spinal cord

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE 65; GLUTAMIC ACID; HISTONE DEACETYLASE; METHIONINE; SMALL INTERFERING RNA; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 2; MEN1 PROTEIN, MOUSE; ONCOPROTEIN;

AMINO ACID ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME INACTIVATION; GENE; GENE SILENCING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOBLOTTING; MALE; MEN1 GENE; MOUSE; NERVE CELL PLASTICITY; NERVE INJURY INDUCED NEUROPATHIC HYPERSENSITIVITY; NEUROPATHIC PAIN; NONHUMAN; PAIN THRESHOLD; PROTEIN EXPRESSION; SPINAL CORD; SYNAPTIC TRANSMISSION; UPREGULATION; VON FREY TEST; ANIMAL; C57BL MOUSE; CHEMISTRY; GENETICS; NEURALGIA; PATHOPHYSIOLOGY; PERIPHERAL NERVE INJURY; PHYSIOLOGY;

ANIMALS; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID; MALE; MICE; MICE, INBRED C57BL; NEURALGIA; PERIPHERAL NERVE INJURIES; PROTO-ONCOGENE PROTEINS; SPINAL CORD;

EID: 84899634577     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2013.06.005     Document Type: Article

References (34)

1. Cruccu G, Truini A. Neuropathic pain and its assessment. Surg Oncol 2010;19:149-54
2. Decosterd I, Woolf CJ. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 2000;87:149-58 (Pubitemid 30621447)
3. Denk F, McMahon SB. Chronic pain: emerging evidence for the involvement of epigenetics. Neuron 2012;73:435-44
4. Foley KM. Opioids and chronic neuropathic pain. N Engl J Med 2003; 348:1279-81 (Pubitemid 36359305)
5. Gwak YS, Hulsebosch CE. GABA and central neuropathic pain following spinal cord injury. Neuropharmacology 2011;60:799-808
6. Haanpää M, Attal N, Backonja M, Baron R, Bennett M, Bouhassira D, et al. NeuPSIG guidelines on neuropathic pain assessment. Pain 2011;152:14-27
7. Harstall C, Ospina M
8. Jarvis MF, Boyce-Rustay JM. Neuropathic pain: models and mechanisms. Curr Pharm Des 2009;15:1711-6
9. Kim J, Kim SJ, Lee H, Chang JW. Effective neuropathic pain relief through sciatic nerve administration of GAD65-expressing rAAV2. Biochem Biophys Res Commun 2009;388:73-8
10. Kim J, Yoon YS, Lee H, Chang JW. AAV-GAD gene for rat models of neuropathic pain and Parkinson's disease. Acta Neurochir Suppl 2008;101:99-105
11. Kubo K, Nishikawa K, Ishizeki J, Hardy-Yamada M, Yanagawa Y, Saito S. Thermal hyperalgesia via supraspinal mechanisms in mice lacking glutamate decarboxylase 65. J Pharmacol Exp Ther 2009;331:162-9
12. Kurreck J. Antisense RNA interference approaches to target validation in pain research. Curr Opin Drug Discov Devel 2004;7:179-87 (Pubitemid 44111949)
13. Martin DL, Barke KE. Are G.A.D65 GAD67 associated with specific pools of GABA in brain? Perspect Dev Neurobiol 1998;5:119-29
14. Martin DL, Rimvall K. Regulation of gamma-aminobutyric acid synthesis in the brain. J Neurochem 1993;60:395-407 (Pubitemid 23030931)
15. Matoso A, Zhou Z, Hayama R, Flesken-Nikitin A, Nikitin AY. Cell lineage-specific interactions between Men1 and Rb in neuroendocrine neoplasia. Carcinogenesis 2008;29:620-8 (Pubitemid 351404880)
16. Moore KA, Kohno T, Karchewski LA, Scholz J, Baba H, Woolf CJ. Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J Neurosci 2002;22:6724-31 (Pubitemid 35386428)
17. Moulder KL, Meeks JP, Mennerick S. Homeostatic regulation of glutamate release in response to depolarization. Mol Neurobiol 2006;33:133-53 (Pubitemid 43780371)
18. Patel AB, de Graaf RA, Martin DL, Battaglioli G, Behar KL. Evidence that GAD65 mediates increased GABA synthesis during intense neuronal activity in vivo. J Neurochem 2006;97:385-96
19. Pittler MH, Ernst E. Complementary therapies for neuropathic and neuralgic pain: systematic review. Clin J Pain 2008;24:731-3
20. Quintero L, Cardenas R, Suarez-Roca H. Stress-induced hyperalgesia is associated with a reduced and delayed GABA inhibitory control that enhances post-synap-tic NMDA receptor activation in the spinal cord. Pain 2011;152:1909-22
21. Sadosky A, McDermott AM, Brandenburg NA, Strauss M. A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neural-gia, and less commonly studied neuropathic pain conditions. Pain Pract 2008;8:45-56
22. Smith BH, Torrance N. Epidemiology of neuropathic pain and its impact on quality of life. Curr Pain Headache Rep 2012;16:191-8
23. Somers DL, Clemente FR. Dorsal horn synaptosomal content of aspartate, glutamate, glycine and GABA are differentially altered following chronic constriction injury to the rat sciatic nerve. Neurosci Lett 2002;323:171-4 (Pubitemid 34311904)
24. Spitzer NC. Activity-dependent neurotransmitter respecification. Nat Rev Neurosci 2012;13:94-106
25. Thomas Cheng H. Spinal cord mechanisms of chronic pain and clinical impli-cations. Curr Pain Headache Rep 2010;14:213-20
26. Tian N, Petersen C, Kash S, Baekkeskov S, Copenhagen D, Nicoll R. The role of the synthetic enzyme GAD65 in the control of neuronal gamma-aminobutyric acid release. Proc Natl Acad Sci USA 1999;96:12911-16 (Pubitemid 29513602)
27. van Kesteren RE, Syed NI, Munno DW, Bouwman J, Feng ZP, Geraerts WP, et al. Synapse formation between central neurons requires postsynaptic expression of the MEN1 tumor suppressor gene. J Neurosci 2001;21:RC161
28. Vianello M, Tavolato B, Giometto B. Glutamic acid decarboxylase autoanti-bodies and neurological disorders. Neurol Sci 2002;23:145-51 (Pubitemid 35345488)
29. Vorobeychik Y, Gordin V, Mao J, Chen L.Combination therapy for neuropathic pain: a review of current vidence.CNS Drugs,2011.25:1023-34
30. Wang F, Shen X, Guo X, Peng Y, Liu Y, Xu S, et al. Spinal macrophage migration inhibitory factor contributes to the pathogenesis of inflammatory hyperalge-sia in rats. Pain 2010;148:275-83
31. Wheal HV, Chen Y, Mitchell J, Schachner M, Maerz W, Wieland H, et al. Molecular mechanisms that underlie structural and functional changes at the postsynaptic membrane during synaptic plasticity. Prog Neurobiol 1998;55:611-40 (Pubitemid 28293584)
32. Xu S, Wu H, Wang X, Shen X, Guo X, Shen R, et al.Tumor suppressor menin mediates peripheral nerve injury induced neuropathic pain through potenti-ating synaptic plasticity.Neuroscience,2012.223:473-85
33. Zhang X, Chen G, Xue Q, Yu B. Early changes of beta-Catenins and Menins in spinal cord dorsal horn after peripheral nerve injury. Cell Mol Neurobiol 2010;30:885-90
34. Zhang Z, Cai YQ, Zou F, Bie B, Pan ZZ. Epigenetic suppression of GAD65 expression mediates persistent pain. Nat Med 2011;17 1448-55.